Left ventricular non-compaction in children and adolescents: clinical features, treatment and follow-up

Yakup Ergul1, Kemal Nisli, Atalay Demirel

  • 1Department of Pediatric Cardiology, Istanbul University, Istanbul Faculty of Medicine, Turkey. yakupergul77@hotmail.com

Cardiology Journal
|March 25, 2011
PubMed

Insights

Left ventricular non-compaction (LVNC) is a rare heart muscle disease diagnosed in children. Early recognition of symptoms like heart failure and cardiomegaly is crucial for timely diagnosis and management of pediatric LVNC.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Cardiomyopathy Research

Background:

  • Left ventricular non-compaction (LVNC) is a distinct cardiomyopathy arising from disrupted endomyocardial morphogenesis.
  • This study focuses on the clinical presentation, diagnostic markers, therapeutic interventions, and outcomes of pediatric patients diagnosed with LVNC.

Purpose of the Study:

  • To present comprehensive clinical findings, diagnostic features, treatment strategies, and follow-up data for pediatric patients with LVNC.
  • To highlight the variability in clinical course and age of diagnosis for LVNC in children.
  • To emphasize the importance of recognizing specific symptoms for earlier LVNC diagnosis.

Main Methods:

  • Retrospective analysis of pediatric patients diagnosed with LVNC between January 2006 and March 2010.
  • Diagnosis confirmed via characteristic findings on magnetic resonance imaging (MRI) and echocardiography.
  • Additional diagnostic tools included Holter electrocardiography and metabolic screening.

Main Results:

  • The study included 24 pediatric patients (18 male, 6 female) with LVNC, diagnosed between 8 days and 15 years of age.
  • Common presenting symptoms included heart failure (33%), rhythm abnormalities (20%), and cardiomegaly (20%). Electrocardiographic abnormalities were prevalent (87.5%).
  • Follow-up revealed the need for a pacemaker in one patient, and three patient deaths. Metabolic disorders were identified in two patients.

Conclusions:

  • LVNC can be diagnosed across all pediatric age groups, from neonates to adolescents, exhibiting a variable clinical trajectory.
  • Prompt evaluation of children presenting with cardiomegaly and heart failure is essential to expedite LVNC diagnosis.
  • Increased awareness and diagnostic vigilance can improve outcomes for pediatric patients with LVNC.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...